iMDsoft's Decision Support Tools Help Dramatically Reduce Errors, Improve Protocol Compliance and Enhance Financial Performance

iMDsoftiMDsoft®'s Clinical Information Systems, coupled with MetaVision Event ManagerTM, are proven to significantly improve care quality and efficiency, to increase adherence to regulations and protocols and to deliver financial benefits. Hospitals using iMDsoft's products have reported outcomes that include increased revenue, reduced prescription errors and adverse events, improved nutrition in the ICU and increased adherence with PONV guidelines, PQRI measures and organ donation guidelines.

MetaVision Event Manager from iMDsoft is a decision support tool that uses branching, longitudinal logic to track changes in patient status and deviations from clinical or administrative protocols. Event Manager issues smart notifications when specific changes in a patient's condition are detected, enabling timely clinical responses. It sends on-screen, email, or SMS reminders for required actions such as initiating or discontinuing medications, performing tests, or taking recommended safety measures. Event Manager can also help contain costs by presenting clinicians with valuable opportunities to make fiscally responsible decisions.

The following research highlights the high impact results hospitals have achieved using MetaVision®’s decision support tools:

Schneider Children's Medical Center, Israel:
MetaVision prevents weight-based calculation errors, which are of particular significance in pediatrics. Adverse drug events were reduced by 72%, while medication prescription errors fell from 5.5% to a mere 0.7% (Pediatrics, Vol. 124, No. 3, September 2009, pp. 935-940).

VU University Medical Center, the Netherlands:
MetaVision allows for improved early delivery of nutrition in the ICU. Using Event Manager, the percentage of patients with adequate nutrients delivered by day 4 in the ICU increased from 30.2% to 56.5%, in accordance with ICU guidelines (The Netherlands Journal of Medicine, Vol. 67, No. 11, December 2009).

OLVG hospital, the Netherlands:
MetaVision dramatically increases adherence to prophylaxis administration guidelines. Timely delivery of both dexamethasone and granisetron increased from 39% to 79% (European Journal of Anaesthesiology, Vol 27 - Issue 2 pp. 187–191 February 2010).

Henry Ford Hospital, US:
MetaVision dramatically improves regulatory compliance, increasing organ donation conversion rate from 64% to 86%. Event Manager enabled the hospital to comfortably exceed the CMS and Joint Commission national goal of 75%.

Massachusetts General Hospital (MGH), US:
MGH implemented an extensive research and education program exploring the safety and effectiveness of drug alternatives (higher vs. lower cost). After MGH set up prompts using Event Manager for drug optimization during long surgeries, the program saved the hospital $700,000 over a period of 16 months.

Lehigh Valley Hospital (LVH), US:
MetaVision significantly enhances compliance with PQRI Measure 193 - Perioperative Temperature Management, designed to reduce the incidence of perioperative hypothermia. Compliance has increased from 60% to 92% since LVH implemented MetaVision Event Manager.

"Given the growing complexity of regulations and clinical workflow, hospitals need advanced clinical information systems that feature powerful decision support tools," said Phyllis Gotlib, CEO, iMDsoft. "iMDsoft clients all over the world report concrete, quantifiable improvements in patient safety, adherence to clinical and administrative protocols, and better financial performance."

About iMDsoft
iMDsoft is a leading provider of Clinical Information Systems (CIS) for perioperative, critical, and acute care. The company's flagship family of solutions, the MetaVision Suite, was first implemented in 1999. It has since become a market leader, with implementations in a wide range of ICUs, ORs, and general wards. iMDsoft products demonstrate a 100% customer retention rate and 100% implementation success rate. Major medical centers across the US, Europe, Asia, and Australia use iMDsoft's technology to improve care quality, promote patient safety, enhance financial performance, support research and compliance, and achieve sustainable market leadership. To learn more, visit www.imd-soft.com.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...